지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 113 - 122 (10page)
이용수
초록· 키워드
오류제보하기
Objectives : Alcoholic fatty liver is an early and reversible consequence of excessive alcohol consumption. The initial hepatocyte cell death stimulates subsequent inflammatory responses, leading to further liver injury and fibrosis. The objective of this study is to investigate the effects of Injinsaryung-san extract on the alcoholic fatty liver by chronic EtOH administration. Method : Male Sprague Dawley rats were used in this study. All animals were randomly divided into Normal group, treated with saline (n=10); EtOH group, treated with ethanol (n=10); EtOH+IS group, treated with ethanol+Injinsaryung-san extract (n=10). For oral administration of ethanol in Control and Sample group, the ethanol was dissolved in distilled water in concentrations of 25%(v/v). Throughout the experiment of 8 week, the rats were allowed free access to water and standard chow. Sample group were administrated by Injinsaryung-san extract daily for 8 weeks. Results : The levels of hepatic marker such as aspartate aminotransferase and alanine aminotransferase were altered. Histopathological changes were reduced and the expression of tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$) was markedly attenuated by Injinsaryung-san extract. Conclusion : These data suggest that Injinsaryung-san extract could be effective in protecting the liver from alcoholic fatty liver. The hepatoprotective mechanisms of Injinsaryung-san may be related to attenuation of $TNF-{\alpha}$ protein, as well as to the inhibition of inflammatory response in the liver. Therefore, Injinsaryung-san can be a candidate to protect against alcoholic fatty liver.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Clinical and Molecular Hepatology
2023 .02
-
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Clinical and Molecular Hepatology
2023 .04
-
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
-
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
-
Long working hours and the risk of non-alcoholic fatty liver disease: a cohort study
대한직업환경의학회 학술대회 논문집
2020 .11
-
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
Diabetes and Metabolism Journal
2022 .07
-
Novel predictive markers for non-alcoholic fatty liver disease: animal and human studies
한국실험동물학회 학술발표대회 논문집
2016 .08
-
Reply to Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Clinical and Molecular Hepatology
2023 .01
-
Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
Clinical and Molecular Hepatology
2022 .10
-
Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
Clinical and Molecular Hepatology
2022 .10
-
Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Clinical and Molecular Hepatology
2023 .01
-
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
-
Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study
Clinical Hypertension
2015 .01
-
Prognosis and problems after LT for alcoholic liver disease
한국간담췌외과학회 학술대회지
2016 .04
-
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
Clinical and Molecular Hepatology
2020 .01
-
The Risk of Abdominal Obesity according to the Degree of Non- Alcoholic Fatty Liver Disease in Korean Men
Journal of Korean Medical Science
2016 .01
-
Liver
대한외과학회 학술대회 초록집
2016 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0